Ocular Blood Flow in Glaucoma Patients

Status Completed

Clinical Trial Summary

Glaucoma is a leading cause of blindness worldwide, whose treatment - intraocular pressure lowering - is only partially effective in preventing disease progression. Accordingly, other variables, such as ocular blood flow-related factors, have been implicated in disease pathogenesis. However, most findings involving vascular variables come from partial, small-scale studies. Furthermore, recent technological advances have identified a number of ocular blood flow variables that have yet to be tested in large scale trials. Therefore, a study that specifically aims at uncovering the role of vascular aspects in glaucoma is needed.

For this purpose, a cross-sectional, observational case-control study will be conducted in the University Hospitals Leuven. This will be the largest-yet study on the subject, involving more than 750 patients. This will allow the creation of a specific cohort of patients where the vascular aspects are thought to be particularly important (low-tension glaucoma). It will use the largest combination yet of vascular-related measuring techniques (dynamic contour tonometry, optic coherent tomography, colour Doppler imaging and retinal oximetry)

Clinical Trial Description

1. Demographic and clinical ophthalmology-related examination data will be collected, including intraocular pressure measurement using dynamic contour tonometry

2. Visual field testing will be performed.

3. Structural damage will be documented by a retinal nerve fiber layer analysis (through Heidelberg Retinal Tomograph)

4. High Definition Optical coherent tomograph imaging of the submacular and peripapillary choroidal thickness will be performed.

5. Color Doppler Imaging of the retrobulbar vessels will be performed, with analysis of the Doppler waveform (peak systolic, end diastolic velocities and resistivity index)

6. Retinal oximetry will be performed with the analysis of the arterial and venous saturations of retinal vessels ;

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01840202
Study type	Observational
Source	Universitaire Ziekenhuizen Leuven
Contact
Status	Completed
Phase	N/A
Start date	February 2013
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03284853` - Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension	Phase 3
Terminated	`NCT03611530` - CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma	N/A
Not yet recruiting	`NCT02868502` - Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma	N/A
Completed	`NCT02628223` - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma	N/A
Completed	`NCT02272569` - STARflo European Safety and Efficacy Study	N/A
Completed	`NCT01936389` - A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma	Phase 2
Completed	`NCT00941525` - Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure	Phase 4
Completed	`NCT00539526` - Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues	Phase 4
Completed	`NCT00121147` - Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan	N/A
Active, not recruiting	`NCT05035394` - Swedish Microinvasive Glaucoma Surgery Study (SMIGS)	N/A
Completed	`NCT03450629` - Evaluation of Safety and Efficacy of PDP-716	Phase 3
Recruiting	`NCT06061718` - Travoprost Intraocular Implant in Conjunction With Cataract Surgery	Phase 3
Recruiting	`NCT05241938` - PSLT Compared to Prostaglandin Analogue Eye Drops	N/A
Completed	`NCT01342406` - Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Completed	`NCT02250612` - SYL040012, Treatment for Open Angle Glaucoma	Phase 2
Completed	`NCT01937312` - Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue	Phase 4
Terminated	`NCT01983579` - TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection	Phase 4
Completed	`NCT01937299` - Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®	Phase 4
Completed	`NCT01229982` - A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma	Phase 2
Recruiting	`NCT00440336` - Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms